Notice: Function _load_textdomain_just_in_time was called incorrectly. Translation loading for the wordpress-seo domain was triggered too early. This is usually an indicator for some code in the plugin or theme running too early. Translations should be loaded at the init action or later. Please see Debugging in WordPress for more information. (This message was added in version 6.7.0.) in /var/www/html/wp-includes/functions.php on line 6260 Sanofi-aventis Enters Consumer Healthcare Market in China - Nutraceuticals World

What are you searching for?

Sign in
Market Updates

Sanofi-aventis Enters Consumer Healthcare Market in China

Author Image

By: Sean Moloughney

Editor, Nutraceuticals World

Paris, France-based Sanofi-aventis has signed an agreement with Minsheng Pharmaceutical Co., Ltd to form a new consumer healthcare joint venture in China. Subject to certain conditions and regulatory approvals, Sanofi-aventis is to obtain a majority equity stake in the new venture. The intended joint venture will focus primarily on vitamin and mineral supplements, the largest consumer healthcare segment in China, where Minsheng has established a strong presence with its flagship multivitamin brand, 21 Super-Vita. Globally, Sanofi-aventis is the fifth largest consumer healthcare company, and the French group continues to expand its presence through mergers and acquisitions. Most recently, Sanofi-aventis announced its planned acquisition of Chattem Inc., a leading manufacturer and marketer of branded consumer healthcare products, toiletries and dietary supplements in the U.S.

Add us as a preferred source on Google

Get the latest Nutraceuticals World news, insights and analysis in your Google Search and AI experiences.

Add Nutraceuticals World as a preferred source on Google (opens in a new tab)

Keep Up With Our Content. Subscribe To Nutraceuticals World Newsletters

Topics